STAT

STAT+: Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules

Pfizer and BioNTech plan to apply Friday to the FDA for an emergency use authorization for their Covid-19 vaccine, a watershed moment in the effort to curb the global pandemic.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our since the holiday is nearing or sound an alarm if you stumble across evidence of election fraud. Perhaps you might reach out to someone feeling isolated. Well, whatever you do, have a grand time. But be safe —wear a mask. Enjoy, and see you soon. …

Sie lesen eine Vorschau. Registrieren Sie sich, um mehr zu lesen.

Mehr von STAT

STAT1 min gelesenMedical
STAT+: Pharmalittle: Novavax Faces Raw-materials Shortages For Covid-19 Shot; India Curbs Vaccine Exports
Novavax is delaying signing a contract to supply its Covid-19 vaccine to the European Union because the company is struggling to source raw materials.
STAT1 min gelesenMedical
STAT+: Pharmalittle: Single Pfizer Shot Is 85% Effective In Preventing Symptomatic Covid-19; Biden To Commit $4 Billion To COVAX
An Israeli study found that a single shot of the Covid-19 vaccine from Pfizer (PFE) and BioNTech (BNTX) is 85% effective in preventing symptomatic disease.
STAT1 min gelesenMedical
STAT+: Pharmalittle: J&J Seeks Emergency Use For Its Coronavirus Vaccine; Merck Says Parasite Drug Does Not Work On Covid-19
Johnson & Johnson has applied to the FDA for an emergency use authorization for its one-dose Covid-19 vaccine, setting in motion a process all but sure to see a third…